The World Health Organization (WHO) has released its first-ever global report on hypertension. The report sheds light on the growing incidences of the silent killer and reveals alarming data of the prevalence of the disease across countries. The number of people living with hypertension has doubled from 650 million to 1.3 billion between 1990 and 2019. Hypertension affects one-third of the population worldwide and if proper treatment is made available to people, close to 76 million deaths could be avoided between 2023 and 2050, the WHO said.
The Indian Hypertension Control Initiative (IHCI) is a significant public health program aimed at addressing the growing burden of hypertension, also known as high blood pressure, in India. Hypertension is a major risk factor for heart disease, stroke, and other cardiovascular conditions, making it a critical health concern in the country. While I don't have access to real-time data beyond my last knowledge update in September 2021, I can provide you with information on the IHCI up to that point.
The IHCI was launched in 2017 as a collaborative effort between the Ministry of Health and Family Welfare of the Government of India, the Indian Council of Medical Research (ICMR), and the World Health Organization (WHO). The initiative's primary goal is to improve hypertension detection, treatment, and control rates across India. Here are some key aspects of the IHCI:
1. **Awareness and Education:** The IHCI focuses on raising awareness about hypertension and its risk factors among healthcare professionals and the general population. This includes training healthcare workers to accurately measure blood pressure and educate patients about hypertension.
2. **Standardized Treatment:** IHCI encourages the use of evidence-based guidelines for the diagnosis and treatment of hypertension. It emphasizes the importance of using generic drugs to make treatment more affordable and accessible.
3. **Technology Integration:** The initiative leverages technology, including mobile health (mHealth) solutions, to streamline data collection, patient monitoring, and follow-up care. These innovations help in tracking patients' progress and ensuring they adhere to treatment plans.
4. **Community Engagement:** IHCI recognizes the role of community-based programs in hypertension control. It encourages community health workers to support hypertension screening and management at the grassroots level.
5. **Public-Private Partnerships:** The IHCI promotes collaboration between government healthcare systems and the private sector to expand access to hypertension care.
6. **Research and Evaluation:** Ongoing research and evaluation are critical components of the IHCI. Monitoring and assessing the initiative's impact help in refining strategies and achieving better outcomes.
It's worth noting that the success and impact of the IHCI may have evolved since my last update. However, as of my last knowledge update, the initiative was a promising step toward addressing the hypertension epidemic in India, with the potential to improve the health and well-being of millions of people. For the most current information, I recommend checking the latest reports and publications related to the Indian Hypertension Control Initiative.
Close to 5.8 million hypertension patients across 27 states were being treated under the Indian Hypertension Control Initiative as of June 2023, the WHO report said, and pointed to the availability of medicines as the "biggest challenge". The Indian Hypertension Control Initiative aims to achieve the government's objective of reducing premature mortality from non-communicable diseases by 25 percent by 2025 through evidence-based strategies to strengthen the building blocks of hypertension management and control.
The initiative was launched in 2017 and involves the Ministry of Health & Family Welfare, Indian Council of Medical Research, State Governments, and WHO-India.
Under the Indian Hypertension Control Initiative which was enabled by support from WHO consultants, 27 Indian states and union territories had developed a standard treatment protocol for hypertension, based on the WHO HEARTS technical package, said the 'Global Report on Hypertension'.
Developed to help countries with cardiovascular disease management in primary health care, the package describes cost-effective strategies to control blood pressure and prevent heart attack, stroke and other complications, it said.
Components of the package include standardized drug- and dose-specific treatment protocol, uninterrupted access to quality medications and a monitoring system to track patient progress and health system performance, it said.
You must be logged in to post a comment.